Active Ingredient(s):Carbidopa FDA Approved: * April 25, 1977 Pharm Company: *BRISTOL MYERS SQUIBB Category:Parkinsons
Carbidopa (Lodosyn) is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood–brain barrier for central nervous system effect.
2 pharmacology 2
5 External links
Carbidopa inhibits aromatic-L-amino-acid decarboxylase (DOPA decarboxylase or DDC), ...
* May have multiple approval dates, manufacturers, or labelers.